Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
10vPHiD vaccine trial in children with chronic suppurative lung disease
ACTRN12612000034831Phase 4Terminated
- Sponsor
- The University of Queensland
- Start
- Feb 2013
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, randomised trial of 10-valent pneumococcal + Haemophilus influenzae protein D conjugate vaccine in chronic suppurative lung disease (CSLD), bronchiectasis and Protracted bacterial bronchitis (PBB) (2 arms), sponsored by The University of Queensland. Primary endpoint: Respiratory exacerbation rate. Started Feb 2013; status: terminated.
02
Drugs
10-valent pneumococcal + Haemophilus influenzae protein D conjugate vaccine
03
Conditions
chronic suppurative lung disease (CSLD)bronchiectasisProtracted bacterial bronchitis (PBB)
Beyond the preview
Go deeper on ACTRN12612000034831.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12612000034831.